✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)
GENVEC INC
operating · RC 0000934473
Overview
GENVEC INC is a operating registered in GAITHERSBURG, MD, United States. The company operates in the 2834 sector. With reported revenue of 3.7M USD in 2016. Its TraceComp score of 73 (B+) indicates moderate risk with some areas to watch.
Company Information
- Registration Number
- 0000934473
- Legal Form
- operating
- Address
- gaithersburg, md
Financial Profile
Latest filed accounts: FY 2016 · most recent available in public filings
Multi-year financials & ratios
1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Officers & Management
No officers on record.
Research Output
Active research organization. 1,043 publications · 110,577 citations · h-index 174 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Biochemistry, Genetics and Molecular Biology (67%) · Medicine (15%) · Chemistry (13%).
See full research profile — top researchers & publications →
Source: OpenAlex (CC0). Objective publication & citation counts.
Patent Portfolio
Active patent holder. 89 patents · 31 active · 89 granted in the USPTO/EPO record.
See full patent portfolio — most-cited inventions & inventors →
Source: USPTO / EPO open patent data. Objective bibliographic counts.
Risk Signals
No adverse legal events have been recorded for this company.
- Net loss reported in FY 2016
- Altman Z-Score in the distress zone — elevated insolvency risk on the model
Data Sources & Freshness
Data sourced from: bulk register.